Long-term eradication of locally recurrent invasive follicular thyroid carcinoma after taxane-based concomitant chemoradiotherapy

Marshall Tulloch-Reid, Monica C. Skarulis, Steven I. Sherman, Nicholas J. Sarlis, Libero Santarpia

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A 46-year-old woman with history of radioiodine-refractory follicular thyroid carcinoma (FTC) presented with locally recurrent, high-risk, invasive disease. She was treated with paclitaxellcarboplatin concomitant chemoradiotherapy (CRT), which was well tolerated, resulting in complete remission and freedom from residual or recurrent FTC for longer than 5 years until her last follow-up at age 52. This case highlights the possibility of combining taxane-based chemotherapy with definitive radiotherapy (as CRT) for the management of locally aggressive recurrences in poorly differentiated thyroid carcinoma, thereby resulting in rapid and persistent disease eradication. Even in the light of recent data on the potential benefit of novel targeted therapy agents in poorly differentiated thyroid carcinoma, this approach in similar clinical settings deserves future investigation.

Original languageEnglish
Pages (from-to)4665-4671
Number of pages7
JournalAnticancer Research
Volume29
Issue number11
Publication statusPublished - Nov 2009

Fingerprint

Follicular Adenocarcinoma
Chemoradiotherapy
Thyroid Neoplasms
Disease Eradication
Radiotherapy
Recurrence
Drug Therapy
taxane
Therapeutics

Keywords

  • Aerodigestive tract
  • Carboplatin
  • External beam
  • Paclitaxel
  • Radioiodine
  • Radiosensitizer
  • Radiotherapy
  • Taxane

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Long-term eradication of locally recurrent invasive follicular thyroid carcinoma after taxane-based concomitant chemoradiotherapy. / Tulloch-Reid, Marshall; Skarulis, Monica C.; Sherman, Steven I.; Sarlis, Nicholas J.; Santarpia, Libero.

In: Anticancer Research, Vol. 29, No. 11, 11.2009, p. 4665-4671.

Research output: Contribution to journalArticle

Tulloch-Reid, Marshall ; Skarulis, Monica C. ; Sherman, Steven I. ; Sarlis, Nicholas J. ; Santarpia, Libero. / Long-term eradication of locally recurrent invasive follicular thyroid carcinoma after taxane-based concomitant chemoradiotherapy. In: Anticancer Research. 2009 ; Vol. 29, No. 11. pp. 4665-4671.
@article{ec37da9f58fb419693787fc6f6557aaf,
title = "Long-term eradication of locally recurrent invasive follicular thyroid carcinoma after taxane-based concomitant chemoradiotherapy",
abstract = "A 46-year-old woman with history of radioiodine-refractory follicular thyroid carcinoma (FTC) presented with locally recurrent, high-risk, invasive disease. She was treated with paclitaxellcarboplatin concomitant chemoradiotherapy (CRT), which was well tolerated, resulting in complete remission and freedom from residual or recurrent FTC for longer than 5 years until her last follow-up at age 52. This case highlights the possibility of combining taxane-based chemotherapy with definitive radiotherapy (as CRT) for the management of locally aggressive recurrences in poorly differentiated thyroid carcinoma, thereby resulting in rapid and persistent disease eradication. Even in the light of recent data on the potential benefit of novel targeted therapy agents in poorly differentiated thyroid carcinoma, this approach in similar clinical settings deserves future investigation.",
keywords = "Aerodigestive tract, Carboplatin, External beam, Paclitaxel, Radioiodine, Radiosensitizer, Radiotherapy, Taxane",
author = "Marshall Tulloch-Reid and Skarulis, {Monica C.} and Sherman, {Steven I.} and Sarlis, {Nicholas J.} and Libero Santarpia",
year = "2009",
month = "11",
language = "English",
volume = "29",
pages = "4665--4671",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "11",

}

TY - JOUR

T1 - Long-term eradication of locally recurrent invasive follicular thyroid carcinoma after taxane-based concomitant chemoradiotherapy

AU - Tulloch-Reid, Marshall

AU - Skarulis, Monica C.

AU - Sherman, Steven I.

AU - Sarlis, Nicholas J.

AU - Santarpia, Libero

PY - 2009/11

Y1 - 2009/11

N2 - A 46-year-old woman with history of radioiodine-refractory follicular thyroid carcinoma (FTC) presented with locally recurrent, high-risk, invasive disease. She was treated with paclitaxellcarboplatin concomitant chemoradiotherapy (CRT), which was well tolerated, resulting in complete remission and freedom from residual or recurrent FTC for longer than 5 years until her last follow-up at age 52. This case highlights the possibility of combining taxane-based chemotherapy with definitive radiotherapy (as CRT) for the management of locally aggressive recurrences in poorly differentiated thyroid carcinoma, thereby resulting in rapid and persistent disease eradication. Even in the light of recent data on the potential benefit of novel targeted therapy agents in poorly differentiated thyroid carcinoma, this approach in similar clinical settings deserves future investigation.

AB - A 46-year-old woman with history of radioiodine-refractory follicular thyroid carcinoma (FTC) presented with locally recurrent, high-risk, invasive disease. She was treated with paclitaxellcarboplatin concomitant chemoradiotherapy (CRT), which was well tolerated, resulting in complete remission and freedom from residual or recurrent FTC for longer than 5 years until her last follow-up at age 52. This case highlights the possibility of combining taxane-based chemotherapy with definitive radiotherapy (as CRT) for the management of locally aggressive recurrences in poorly differentiated thyroid carcinoma, thereby resulting in rapid and persistent disease eradication. Even in the light of recent data on the potential benefit of novel targeted therapy agents in poorly differentiated thyroid carcinoma, this approach in similar clinical settings deserves future investigation.

KW - Aerodigestive tract

KW - Carboplatin

KW - External beam

KW - Paclitaxel

KW - Radioiodine

KW - Radiosensitizer

KW - Radiotherapy

KW - Taxane

UR - http://www.scopus.com/inward/record.url?scp=75149163332&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75149163332&partnerID=8YFLogxK

M3 - Article

VL - 29

SP - 4665

EP - 4671

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 11

ER -